Substance Use Stigma and Vaccine Hesitancy: Whose Beliefs Did the Survey Measure?
A survey linked negative public attitudes toward people with certain substance-use disorders to COVID-19 vaccine hesitancy. The study did not ask whether people using methamphetamine experienced stigma that caused them to avoid vaccination. Its central measurement was the respondent’s stigmatizing attitude toward other people.
Whose attitudes were measured?
Powell and colleagues analyzed responses from 6,515 adults in an October-November 2021 AmeriSpeak survey. AmeriSpeak is a probability-based household panel. The study was cross-sectional: attitudes, vaccine intentions and other information were collected for the same survey period.
The substance-use scales asked about willingness to work with someone or have that person marry into the family, perceptions of stealing or workplace risk, dangerousness and trustworthiness. Items addressed people described as having a past or current substance-use disorder. Higher scores indicated greater stigma. Separate scales concerned opioids, methamphetamine, cocaine and alcohol.
Hesitancy combined several different answers
Respondents who had already been vaccinated or planned vaccination as soon as possible were classified as not hesitant. The hesitant group combined people planning to wait for more evidence, people saying they would not be vaccinated and people who were unsure.
That combined outcome is broader than refusal. A reported association with hesitancy cannot be restated as an association specifically with permanent refusal, verified failure to receive a dose, or an individual’s future behavior. The definition used in the analysis determines what its result means.
The associations were adjusted group estimates
The reported adjusted odds ratios relating the respective stigma measures to hesitancy were 1.34 for opioids, 1.40 for methamphetamine and 1.28 for cocaine; these associations met the paper’s significance criteria. The alcohol estimate was 1.06 and was not statistically significant.
An odds ratio is not a percentage-point increase in probability. These estimates also describe associations for the scales as modeled, rather than a diagnosis applicable to every person with a particular belief. The models included other demographic and attitudinal information, but adjustment does not establish that all alternative explanations were measured.
Reliability does not establish causation or prediction
The authors reported good internal consistency for the stigma scales. That supports consistency among their component items. It does not prove that stigma causes vaccine hesitancy, that changing one attitude changes the other, or that a scale accurately predicts later vaccination in new individuals.
The paper notes self-report and social-desirability concerns, unmeasured prior COVID-19 infection, and possible nonresponse bias. About 40% of contacted panel members completed this project’s survey; weighting addressed observed demographic differences but cannot guarantee removal of every response bias.
Keep the direction of the question intact
The finding concerns public attitudes toward people with substance-use disorders and the same respondents’ vaccine hesitancy. It should not be transformed into a claim about the vaccine beliefs of all people who use drugs, nor used to characterize an individual patient’s motives. The study offers an exploratory association that may guide additional research, while leaving the causal pathway and intervention effects open.
Scientific source
Powell N, Taylor B, Hotton A, and colleagues. The Relationship between Substance Use Stigma and COVID-19 Vaccine Hesitancy. Vaccines. 2023;11:1194. DOI: 10.3390/vaccines11071194. This analysis uses the supplied historical survey, without treating its 2021 responses as current population estimates.



